Live
Audio Only
The president of Biotechnology and Pharmaceutical Industries (BioCubaFarma), Eduardo Martínez, said that "at the latest, in August, the workers of the BiocubaFarma Marketing and Distribution Company (Emcomed) will have manufactured enough doses to vaccinate the entire Cuban population."
Cuban authorities confirmed on Wednesday that all required doses of its COVID-19 vaccines would be ready by August this year. This, as the country advances on the clinical trials of five vaccine candidates.
RELATED:
US Pressured Panama, Brazil to Reject Sputnik V & Cuban Doctors
The president of Biotechnology and Pharmaceutical Industries (BioCubaFarma), Eduardo Martínez, said that "at the latest, in August, the workers of the BiocubaFarma Marketing and Distribution Company (Emcomed) will have manufactured enough doses to vaccinate the entire Cuban population."
#Soberana01, #Soberana02, #SoberanaPlus, #Abdala y #Mambisa. La Fuerza de Un País: más protegido, más inmune, más feliz. Acompañemos este esfuerzo cumpliendo con las medidas sanitarias #COVID19. pic.twitter.com/1IL7NydWnh
— BioCubaFarma (@BioCubaFarma) March 14, 2021
Although a series of countries have shown interest in acquiring Cuban COVID-19 vaccines and countries such as Iran are participating in phase 3 of clinical trials of the front-runner SBERANA 02, authorities remarked that immunizing the population is a priority.
The Cuban Biopharmaceutical industry has more than five decades of experience manufacturing vaccines and innovative, worldwide-renowned products. In this sense, Martínez said that all technological facilities to produce the COVID-19 vaccines are ready.
#FromTheSouth News Bits | Cuba continues Phase III clinical trials of Soberana 02, which started on March 10 in thirteen clinical sites of the capital, Havana. The intention is to administer vaccines to 44,000 people during this final phase. pic.twitter.com/Y5GI5pKsod
— teleSUR English (@telesurenglish) March 12, 2021
Newsletter
